MUHAMMAD UMAIR IJAZ M.D. NPI 1629490065

NPI Information

  • NPI: 1629490065
  • Provider Name: MUHAMMAD UMAIR IJAZ, M.D.
  • Classification: Internal Medicine - 207RR0500X
  • Specialization: Rheumatology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 104 MILLSAPS DR
    HATTIESBURG, MS
    ZIP 39402
  • Phone: (601) 288-7500

Map and Directions

Get Directions

NPI Details

Muhammad Umair Ijaz, M.D. is a rheumatology internal medicine in Hattiesburg, MS with 18 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. Muhammad Umair Ijaz, M.D. NPI is 1629490065. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

104 MILLSAPS DR
HATTIESBURG, MS
ZIP 39402-328
Phone: (601) 288-7500
Fax: (601) 268-5179

The NPI 1629490065 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
  • Injection, tocilizumab, 1 mg (HCPCS:J3262)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
  • Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
  • Injection, rituximab, 10 mg (HCPCS:J9312)
  • Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg (HCPCS:J7325)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Aspiration and/or injection of fluid from large joint (HCPCS:20610)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Testing for presence of drug, read by direct observation (HCPCS:80305)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Uric acid level, blood (HCPCS:84550)
  • Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose (HCPCS:J7323)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Automated urinalysis test (HCPCS:81003)
  • Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
  • Calcium level, total (HCPCS:82310)
  • New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
  • Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Blood creatinine level (HCPCS:82565)
  • Aspiration and/or injection of fluid from small joint (HCPCS:20600)

The enumeration date for this NPI number is 1/18/2014 and was last updated on 7/9/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RR0500XInternal MedicineRheumatology24235MISSISSIPPIYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
107525065MEDICAIDMISSISSIPPI

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 3/30/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.